Hindawi Publishing Corporation

Evidence-Based Complementary and Alternative Medicine Volume 2013,

Article ID 358673, 11 pages



Swertiamarin: An Active Lead from Enicostemma littorale  Regulates Hepatic and Adipose Tissue Gene Expression by Targeting PPAR-γ and Improves Insulin Sensitivity in Experimental NIDDM Rat Model

Tushar P. Patel, Sanket Soni, Pankti Parikh, Jeetendra Gosai, Ragitha Chruvattil, and Sarita Gupta

Department of Biochemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat-390 005, India.

Correspondence should be addressed to Sarita Gupta : sglmescrl@gmail.com



Enicostemma littorale (EL) Blume is one of the herbs widely used for treating and alleviating the effects of both type I and type II diabetes. However, lack of understanding of mechanism precludes the use of the herb and its molecules. In this study, we attempt to unravel the molecular mechanism of action of swertiamarin, a compound isolated form EL, by comparing its molecular effects with those of aqueous EL extract in alleviating the insulin resistance in type II diabetes. We further investigated hypolipidemic and insulin sensitizing effect of swertiamarin in experimentally induced noninsulin dependent diabetes mellitus (NIDDM) in rats. Swertiamarin (50 mg/kg) and aqueous extract (15 grams dried plant equivalent extract/kg) were administered to rats orally for 40 days and tight regulation of serum glucose, insulin, and lipid profile was found in both groups. Their mode of action was by restoring G6Pase and HMG-CoA reductase activities to normal levels and restoring normal transcriptional levels of PEPCK, GK, Glut 2, PPAR-gamma, leptin, adiponectin, LPL, SREBP-1c, and Glut 4 genes. This suggests that both treatments increased insulin sensitivity and regulated carbohydrate and fat metabolism. This is the first report on the role of SM in regulating the PPARgamma-mediated regulation of candidate genes involved in metabolism in peripheral tissues in vivo.

Keywords: Swertiamarin, Enicostemma littorale, PPAR-gamma, Insulin sensitivity, NIDDM rat model.

Sarita Gupta-fig1

Schematic representation of swertiamarin in amelioration of insulin resistance and TIIDM. Figure shows carbohydrate and fat metabolic pathways and candidate genes which are altered during diabetes. Swertiamarin treatment modulates not only the expression of these target genes which is marked in blue but also the metabolite levels in blood marked in red.

Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann